Read Bill McGivney's editorial comment in OBR regarding an executive order aiming to address high prescription drug prices:
top of page
Search
Recent Posts
See AllBy Jon Larsen, JD, MPP, McGA Policy Consultant In August 2018, the Centers for Medicare and Medicaid Services (CMS) rescinded 2012 guidance that prohibited step therapy from applying to Part B drugs c
bottom of page